about
ERp44, a novel endoplasmic reticulum folding assistant of the thioredoxin familyThiol-mediated protein retention in the endoplasmic reticulum: the role of ERp44Secretion of novel SEL1L endogenous variants is promoted by ER stress/UPR via endosomes and shed vesicles in human cancer cellsPigment epithelium-derived factor is differentially expressed in peripheral neuropathies.Proteomic analysis of activity-dependent synaptic plasticity in hippocampal neurons.Protein fingerprints of cultured CA3-CA1 hippocampal neurons: comparative analysis of the distribution of synaptosomal and cytosolic proteinsThe cooperation between hMena overexpression and HER2 signalling in breast cancerHS1 protein is differentially expressed in chronic lymphocytic leukemia patient subsets with good or poor prognoses.Nonlinear dimension reduction and clustering by Minimum Curvilinearity unfold neuropathic pain and tissue embryological classesAcclimation increases freezing stress response of Arabidopsis thaliana at proteome level.Molecular cloning of hMena (ENAH) and its splice variant hMena+11a: epidermal growth factor increases their expression and stimulates hMena+11a phosphorylation in breast cancer cell lines.The intellectual disability protein RAB39B selectively regulates GluA2 trafficking to determine synaptic AMPAR composition.Ceruloplasmin functional changes in Parkinson's disease-cerebrospinal fluidSerological immune response against ADAM10 pro-domain is associated with favourable prognosis in stage III colorectal cancer patientsMiddle T antigen-transformed endothelial cells exhibit an increased activity of nitric oxide synthase.Human Mena+11a isoform serves as a marker of epithelial phenotype and sensitivity to epidermal growth factor receptor inhibition in human pancreatic cancer cell linesOxidation-induced structural changes of ceruloplasmin foster NGR motif deamidation that promotes integrin binding and signaling.Comparative Proteomics for the Evaluation of Protein Expression and Modifications in Neurodegenerative Diseases.Natural Antibodies to Tumor-Associated Antigens.A possible role of transglutaminase 2 in the nucleus of INS-1E and of cells of human pancreatic isletsProteins from Tuber magnatum Pico fruiting bodies naturally grown in different areas of ItalyTransglutaminase 2 transamidation activity during first-phase insulin secretion: natural substrates in INS-1E.PBX1 nuclear export is regulated independently of PBX-MEINOX interaction by PKA phosphorylation of the PBC-B domain.Serological immunoreactivity against colon cancer proteome varies upon disease progression.Autoantibody signature in human ductal pancreatic adenocarcinoma.Protein disulfide isomerase A3-specific Th1 effector cells infiltrate colon cancer tissue of patients with circulating anti-protein disulfide isomerase A3 autoantibodies.ZAP-70 is expressed by normal and malignant human B-cell subsets of different maturational stage.Evaluation of the molecular mechanisms involved in the gain of function of a Li-Fraumeni TP53 mutation.Synthesis, processing, and intracellular transport of CD36 during monocytic differentiation.Characterization by monoclonal antibody of a highly conserved antigenic determinant expressed on human platelet membranes and intermediate filament type III.Src family kinases are necessary for cell migration induced by extracellular HMGB1.Ceruloplasmin potentiates nitric oxide synthase activity and cytokine secretion in activated microglia.Identification of CD36 molecular features required for its in vitro angiostatic activity.Increased expression of Myosin binding protein H in the skeletal muscle of amyotrophic lateral sclerosis patients.Identification of grass pollen allergens by two-dimensional gel electrophoresis and serological screening.Serological Proteome Analysis (SERPA) as a tool for the identification of new candidate autoantigens in type 1 diabetes.An integrated strategy in two-dimensional electrophoresis analysis able to identify discriminants between different clinical conditions.In vivo microglia activation in very early dementia with Lewy bodies, comparison with Parkinson's disease.Ceruloplasmin replacement therapy ameliorates neurological symptoms in a preclinical model of aceruloplasminemia.Image Pretreatment Tools I: Algorithms for Map Denoising and Background Subtraction Methods.
P50
Q24292308-F65B8439-690E-4B7E-AE80-1D5AD7099982Q24672358-D61FC676-9D11-4964-8555-3FC074F14EDAQ28477193-F77A6810-7509-4339-ABBB-88E4A1A41007Q33224308-7CFED5EF-E11F-45C3-AEA5-039D0C32CB48Q33290417-AECF3A9D-8490-49E3-B67A-446B0FED00BDQ33327562-417034AC-87E2-4C9D-8095-9F199267D07BQ33786779-D5966409-719D-4FA2-AA66-A3A373E1A47BQ33831931-9B209D43-0107-44AF-B674-D1D491F024DFQ34110439-82B5F5CF-ED22-414E-81E7-A305CFEB23C3Q34236183-10713B35-CDF1-4C6B-93C6-C0F9E5738B07Q35165997-49E88CB4-44D8-4803-8095-C8271A509180Q35247088-337AF690-5FAC-4C8F-ABE8-9C7D234B3D13Q35832847-9CE749F7-28CA-4A66-B421-35EA0D2676F9Q36102628-8546595F-AAB6-4C41-9130-6967E916A2BCQ36364302-D8953FA2-DDCF-4DEB-B742-DBB0493D5771Q36982771-4A75E50C-7AE5-46EF-84FA-692D2E2B6CB1Q37563576-B7847048-0EA9-4C48-8D7E-10D1A97C382AQ38575535-D044FC66-688B-4C26-8F64-2FD44D6B5373Q38782056-FB76E97D-1BC2-4946-B405-B0393DCBD0DAQ39051827-2D2B1647-37EF-4F80-96C3-0A550833A217Q39298851-2F2CA322-6721-44DF-ABE5-493A98D4A0BBQ39387300-D816E306-4987-436D-B024-8AD0105DFD76Q39696466-8E4421EE-8E19-4705-8D9A-AF7DCD4B4426Q40027849-B6FC851B-747E-4CC7-B643-3B1D3C995071Q40083640-70056582-395A-454C-96A3-72124762F918Q40102453-B95D2D5B-4377-44C3-8F60-CC8C61A1CB39Q40315561-11FBB538-4E1B-4B9E-A620-BF18A1052B06Q40411164-4DD65DA6-DBCD-4BB8-92C5-F2B647AEDF07Q41237746-C4B56784-75F8-4C0F-94A1-F53CDA7495FEQ41736535-7C756B32-EDBA-4456-A28D-BC3AFB8665D9Q42800376-7022F876-12C6-40BE-903A-14DBEF4D3265Q42914107-CAC37B8B-13DF-47B7-B705-7B61B033D1A5Q43815459-47D79DD7-5FC6-4149-93B9-F14AAC546E81Q44313018-41AFC7CA-386E-42CF-B63D-2DD8281724D2Q45237182-E34324FA-30CA-440B-85F8-58F7E19E5222Q45263012-FDEC81D7-AFBA-41D1-A110-A7A0FF42B809Q45898480-821CE001-6740-4E5E-B021-E5E74590CCE6Q46886801-115BAB67-D6EC-42F0-A7BA-58095C0BCAB6Q47355024-3CC93094-8DBF-440C-8A0A-F0677CEBD899Q50765131-D691E77C-EEB5-4B39-8009-6D6625AB44D6
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Massimo Alessio
@ast
Massimo Alessio
@en
Massimo Alessio
@es
Massimo Alessio
@nl
Massimo Alessio
@sl
type
label
Massimo Alessio
@ast
Massimo Alessio
@en
Massimo Alessio
@es
Massimo Alessio
@nl
Massimo Alessio
@sl
prefLabel
Massimo Alessio
@ast
Massimo Alessio
@en
Massimo Alessio
@es
Massimo Alessio
@nl
Massimo Alessio
@sl
P1053
K-7028-2014
P106
P21
P31
P3829
P496
0000-0002-4133-3472